Info on the dilution and adulteration of copyright will not be routinely gathered in Europe. Nevertheless, dependant on complementary facts reported on the EMCDDA and data obtainable from other sources, some analysis of new trends regarding pharmacologically active adulterants in copyright products

This transcript was made using speech recognition computer software. Although it has been reviewed by human transcribers, it may well include glitches. Remember to overview the episode audio ahead of quoting from this transcript and electronic mail [email protected] with any queries. I